Nebulized albuterol in acute bronchiolitis1

https://doi.org/10.1016/S0022-3476(05)80706-1Get rights and content

In a double-blind, placebo-controlled trial, 40 infants between 6 weeks and 24 months of age who had a first episode of wheezing and other signs and symptoms of bronchiolitis were randomly assigned to receive either nebulized albuterol (0.15 mg/kg/dose) or placebo (saline solution) for two administrations 1 hour apart. The albuterol therapy resulted in a significantly greater improvement in the accessory muscle score (↓0.70 vs ↓0.30; p=0.03), oxygen saturation (↑0.71% vs ↑0.47%; p=0.01) after one dose, and in the accessory muscle score (↑0.86 vs ↑0.37; p=0.02), respiratory rate (↑19.6% vs ↑8.0%; p=0.016), and oxygen saturation (↑0.76% vs ↓0.79%; p=0.015) after two doses of the drug. The response to therapy was similar in infants younger and those older than 6 months of age. The heart rate rose slightly more in the albuterol group (↑7.76 from baseline) versus the placebo group (↓6.79). There were no other side effects of the treatment. Of the 34 children from whom nasal specimens were obtained by swab for viral identification, 24 had positive fest results (21 for respiratory syncytial virus, 1 for parainfluenza, 1 for paramyxovirus, and 1 for influenza A). We conclude that nebulized albuterol constitutes a safe and effective treatment of infants with bronchiolitis.

References (25)

  • LenneyW et al.

    At what age do bronchodilator drugs work?

    Arch Dis Child

    (1978)
  • StokesGM et al.

    Nebulized therapy in acute severe bronchiolitis in infancy

    Arch Dis Child

    (1980)
  • Cited by (150)

    • Acute bronchiolitis

      2013, Pediatric Clinics of North America
      Citation Excerpt :

      Albuterol/salbutamol is the most widely used β2-agonist. Studies in an outpatient setting have shown a modest improvement in O2 saturation or/and clinical score after albuterol treatment.49,50 Studies with hospitalized patients have not demonstrated any clinical benefit for routine care.51,52

    • NONBACTERIAL PNEUMONIA

      2009, Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth Edition
    View all citing articles on Scopus
    1

    Supported by the pediatric consultants of the Hospital for Sick Children, Toronto.

    Presented in part at the American Academy of Pediatrics Meeting (Scientific Section), Chicago, Ill., Oct. 22, 1989.

    View full text